Skip to main content

Table 4 Categorization for primary child outcomes

From: Impact of the Umoyo mother-infant pair model on HIV-positive mothers’ social support, perceived stigma and 12-month retention of their HIV-exposed infants in PMTCT care: evidence from a cluster randomized controlled trial in Zambia

Outcomes

HIV-exposed and -negative

HIV-positive

Change in the proportion of HEIs who were retained in care at 12 months of age

Evidence of 12-month test

• Date of 12-month test date listed; or

• Result of 12-month rapid diagnostic test result listed (i.e., positive or negative)

• Attended 12-month visit if tested positive at 6-week; or

• Attended 12-month visit (i.e., 6-month ARV registry) if tested positive at 6 months

Change in the proportion of HEIs with regular attendance and retained in care at 6, 9, and 12 months of age

Evidence 6-month test occurred:

• Date of either 6-month virologic test date listed; virologic results received listed; or virologic test results collected by mother; or

• Result of 6-month virologic test result listed

and evidence attended 9-month session

• Recorded whether the infant was either breastfeeding, received cotrimoxazole, or received nevirapine at 9-month visit

and evidence of 12-month test

• Date of 12-month test date listed; or

• Result of 12-month rapid diagnostic test result listed (i.e., positive or negative)

• Attended 6-, 9-, and 12-month visit, if tested positive at 6 weeks; or

• Attended 12- and 9-month visit (i.e., 6- and 3-month ARV registry) if tested positive at 6 months

  1. ARV antiretroviral therapy, HEI HIV-exposed infant